These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9118509)

  • 21. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel ELISA system for simultaneous detection of six subclasses of anti-phospholipid antibodies for prediction of thrombotic complications among SLE patients.
    Nojima J; Motoki Y; Aoki N; Tsuneoka H; Ichihara K
    Thromb Res; 2014 Jun; 133(6):1135-40. PubMed ID: 24721837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
    Erkan D; Willis R; Murthy VL; Basra G; Vega J; Ruiz-Limón P; Carrera AL; Papalardo E; Martínez-Martínez LA; González EB; Pierangeli SS
    Ann Rheum Dis; 2014 Jun; 73(6):1176-80. PubMed ID: 23933625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C; Meyer O; Dosquet C; Montes de Oca M; Babron MC; Danon F; Kaplan C; Clémenceau S; Castellano F; Levy M
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
    Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
    Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
    Ginsberg JS; Demers C; Brill-Edwards P; Bona R; Johnston M; Wong A; Denburg JA
    Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
    Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
    Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
    Radway-Bright EL; Ravirajan CT; Isenberg DA
    Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies.
    Dhillon PK; Khalafallah AA; Adams MJ
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):870-875. PubMed ID: 27167859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.